DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers
Zsuzsanna Suba Surgical and Molecular Tumor Pathology Centre, National Institute of Oncology, Budapest, Hungary Abstract: Currently available scientific evidence erroneously suggests that mutagenic weakness or loss of the BRCA1/2 genes may liberate the proliferative effects of estrogen signaling, wh...
Saved in:
Main Author: | Suba Z (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylactic adnexectomy in BRCA1 and BRCA2 gene mutation carriers (а review of literature)
by: T. A. Shendrikova, et al.
Published: (2014) -
Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis
by: Nadav Michaan, et al.
Published: (2021) -
Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020) -
Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series
by: Koji Matsuo, et al.
Published: (2018) -
Editorial: BRCA1 and BRCA2 genes mutations screening in sporadic breast cancer patients in Kazakhstan
by: Rachel C. Jankowitz, et al.
Published: (2013)